Literature DB >> 26991857

Impact of the functional CD5 polymorphism A471V on the response of chronic lymphocytic leukaemia to conventional chemotherapy regimens.

Julio Delgado1, Torsten Bielig2, Lizette Bonet2, Elena Carnero-Montoro3, Xose S Puente4, Dolors Colomer5, Elena Bosch3, Elias Campo5, Francisco Lozano2,6,7.   

Abstract

Entities:  

Keywords:  B-cell receptor signalling; B1a lymphocytes; CD5 polymorphism; chronic lymphocytic leukaemia; progression-free survival

Mesh：

Substances：

Year:  2016        PMID： 26991857      PMCID： PMC5381713          DOI： 10.1111/bjh.14037

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  15 in total

1.  CD5 is associated with the human B cell antigen receptor complex.

Authors:  A C Lankester; G M van Schijndel; J L Cordell; C J van Noesel; R A van Lier
Journal:  Eur J Immunol       Date:  1994-04       Impact factor: 5.532

2.  B-cell receptor signaling in chronic lymphocytic leukemia.

Authors:  Freda K Stevenson; Sergey Krysov; Andrew J Davies; Andrew J Steele; Graham Packham
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

3.  CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells.

Authors:  G Bikah; J Carey; J R Ciallella; A Tarakhovsky; S Bondada
Journal:  Science       Date:  1996-12-13       Impact factor: 47.728

4.  Non-coding recurrent mutations in chronic lymphocytic leukaemia.

Authors:  Xose S Puente; Silvia Beà; Rafael Valdés-Mas; Neus Villamor; Jesús Gutiérrez-Abril; José I Martín-Subero; Marta Munar; Carlota Rubio-Pérez; Pedro Jares; Marta Aymerich; Tycho Baumann; Renée Beekman; Laura Belver; Anna Carrio; Giancarlo Castellano; Guillem Clot; Enrique Colado; Dolors Colomer; Dolors Costa; Julio Delgado; Anna Enjuanes; Xavier Estivill; Adolfo A Ferrando; Josep L Gelpí; Blanca González; Santiago González; Marcos González; Marta Gut; Jesús M Hernández-Rivas; Mónica López-Guerra; David Martín-García; Alba Navarro; Pilar Nicolás; Modesto Orozco; Ángel R Payer; Magda Pinyol; David G Pisano; Diana A Puente; Ana C Queirós; Víctor Quesada; Carlos M Romeo-Casabona; Cristina Royo; Romina Royo; María Rozman; Nuria Russiñol; Itziar Salaverría; Kostas Stamatopoulos; Hendrik G Stunnenberg; David Tamborero; María J Terol; Alfonso Valencia; Nuria López-Bigas; David Torrents; Ivo Gut; Armando López-Guillermo; Carlos López-Otín; Elías Campo
Journal:  Nature       Date:  2015-07-22       Impact factor: 49.962

Review 5.  The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.

Authors:  Gloria Soldevila; Chander Raman; Francisco Lozano
Journal:  Curr Opin Immunol       Date:  2011-04-07       Impact factor: 7.486

6.  Evolutionary and functional evidence for positive selection at the human CD5 immune receptor gene.

Authors:  Elena Carnero-Montoro; Lizette Bonet; Johannes Engelken; Torsten Bielig; Mario Martínez-Florensa; Francisco Lozano; Elena Bosch
Journal:  Mol Biol Evol       Date:  2011-10-13       Impact factor: 16.240

7.  A role for CD5 in TCR-mediated signal transduction and thymocyte selection.

Authors:  A Tarakhovsky; S B Kanner; J Hombach; J A Ledbetter; W Müller; N Killeen; K Rajewsky
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

8.  Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis.

Authors:  Gabrielle S Sellick; Rachel Wade; Susan Richards; David G Oscier; Daniel Catovsky; Richard S Houlston
Journal:  Blood       Date:  2007-11-15       Impact factor: 22.113

9.  Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production.

Authors:  Hélène Gary-Gouy; Julie Harriague; Georges Bismuth; Cornelia Platzer; Christian Schmitt; Ali H Dalloul
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

10.  Analysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients.

Authors:  Maria Carmen Cenit; Mario Martínez-Florensa; Marta Consuegra; Lizette Bonet; Elena Carnero-Montoro; Noelia Armiger; Miguel Caballero-Baños; Maria Teresa Arias; Daniel Benitez; Norberto Ortego-Centeno; Enrique de Ramón; José Mario Sabio; Francisco J García-Hernández; Carles Tolosa; Ana Suárez; Miguel A González-Gay; Elena Bosch; Javier Martín; Francisco Lozano
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240
View more
  7 in total

1.  Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.

Authors:  Marta Consuegra-Fernández; Marc Julià; Mario Martínez-Florensa; Fernando Aranda; Cristina Català; Noelia Armiger-Borràs; María-Teresa Arias; Francisca Santiago; Antonio Guilabert; Anna Esteve; Carlos Muñoz; Carlos Ferrándiz; José-Manuel Carrascosa; Edurne Pedrosa; Jorge Romaní; Mercè Alsina; José-Manuel Mascaró-Galy; Francisco Lozano
Journal:  Cell Mol Immunol       Date:  2017-12-11       Impact factor: 11.530

2.  Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival.

Authors:  Miriam Potrony; Esther Carreras; Fernando Aranda; Lisa Zimmer; Joan-Anton Puig-Butille; Gemma Tell-Martí; Noelia Armiger; Antje Sucker; Pol Giménez-Xavier; Mario Martínez-Florensa; Cristina Carrera; Josep Malvehy; Dirk Schadendorf; Susana Puig; Francisco Lozano
Journal:  Int J Cancer       Date:  2016-05-31       Impact factor: 7.396

3.  Immunomodulatory effects of soluble CD5 on experimental tumor models.

Authors:  Inês T Simões; Fernando Aranda; Esther Carreras; Maria Velasco-de Andrés; Sergi Casadó-Llombart; Vanesa G Martinez; Francisco Lozano
Journal:  Oncotarget       Date:  2017-11-20

4.  Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies.

Authors:  Songnan Sui; Zhiyan Li; Jiaxiong Tan; Liang Wang; Gengxin Luo; Chengwu Zeng; Oscar Junhong Luo; Cunte Chen; Yangqiu Li
Journal:  J Oncol       Date:  2022-08-09       Impact factor: 4.501

5.  Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease.

Authors:  Sergi Casadó-Llombart; María Velasco-de Andrés; Cristina Català; Alejandra Leyton-Pereira; Rebeca Gutiérrez-Cózar; Belén Suárez; Noelia Armiger; Esther Carreras; Miriam Esteller; Elena Ricart; Ingrid Ordás; Javier P Gisbert; María Chaparro; María Esteve; Lucía Márquez; David Busquets; Eva Iglesias; Esther García-Planella; María Dolores Martín-Arranz; Juliane Lohmann; C Korcan Ayata; Jan Hendrik Niess; Pablo Engel; Julián Panés; Azucena Salas; Eugeni Domènech; Francisco Lozano
Journal:  Front Immunol       Date:  2022-09-21       Impact factor: 8.786

6.  Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.

Authors:  Sergi Casadó-Llombart; Tarek Ajami; Marta Consuegra-Fernández; Esther Carreras; Fernando Aranda; Noelia Armiger; Antonio Alcaraz; Lourdes Mengual; Francisco Lozano
Journal:  Prostate       Date:  2022-06-29       Impact factor: 4.012

Review 7.  Contribution of Evolutionary Selected Immune Gene Polymorphism to Immune-Related Disorders: The Case of Lymphocyte Scavenger Receptors CD5 and CD6.

Authors:  Sergi Casadó-Llombart; María Velasco-de Andrés; Cristina Català; Alejandra Leyton-Pereira; Francisco Lozano; Elena Bosch
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.